B. Metzler Seel. Sohn & Co. Holding Ag Acadia Pharmaceuticals Inc Put Options Transaction History
B. Metzler Seel. Sohn & Co. Holding Ag
- $10.1 Trillion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ACAD
# of Institutions
288Shares Held
160MCall Options Held
723KPut Options Held
257K-
Baker Bros. Advisors LP New York, NY42.9MShares$769 Million9.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.8MShares$248 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY13.7MShares$246 Million3.72% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$216 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$104 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.9B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...